How Mattress Mack helped bring an important medical breakthrough to life
The revolutionary BiVACOR heart device was moved to Phase 2 of FDA trials after success in five human patients.
Endocrinology Advisor22h
SGLT2 Inhibitors Confer Greater Cardioprotective Effect in Older Adults With T2D
SGLT2 inhibitors were associated with better cardioprotective effects among older adults than younger adults with type 2 diabetes.
Study yields unexpected results from empagliflozin after heart attack
A new study, authored by KBH Professor Jan Inge Henter and published in the New England Journal of Medicine, has investigated ...
TCTMD1d
Aortic Stenosis Slowed by SGLT2 Inhibitors in Observational Study
If validated prospectively, the findings could be ‘transformative’ for patients with no current medical options.
Cochrane3d
Does treatment with GLP-1 receptor agonists prevent complications for people with chronic kidney disease and diabetes?
• Glucagon-like peptide 1 receptor agonists (GLP-1) (medicines used to lower blood glucose) probably reduce the risk of death due to any cause but may have little or no death due to a heart attack in ...
Heart Failure Deaths Are Increasing. New Treatments Could Help.
The deaths are also partly the result of medical successes: People are living longer, and more people are surviving heart ...
‘First of its kind’ medication can significantly reduce heart attacks and strokes
A new study found that a drug recently approved to treat type 2 diabetes and kidney disease in patients with additional ...